| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5675785 | American Journal of Obstetrics and Gynecology | 2017 | 8 Pages |
Abstract
Rates of recurrent preeclampsia among women with a history of preeclampsia decreased by 30% after release of the US Preventive Services Task Force recommendation for aspirin for preeclampsia prevention. Future prospective studies should include direct measures of aspirin compliance, gestational age at initiation, and explore the influence of race and ethnicity on the efficacy of this primary prevention.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Mary Catherine MD, MS, Derrick M. BS, Lisa M. MD, Joan M. MD, Diana A. MD, Susan M. MD, Haleh PhD, Kjersti M. MD, PhD,